Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GATE: Dulaglutide on fluid intake in healthy volunteers
NCT03141632Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Oct 2016
- Primary completion
- May 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in primary polydipsia (PP) and water-electrolyte imbalance comparing Dulaglutide Arm with Placebo Arm (2 arms). Primary endpoint: Fluid intake at 8 hours. Started Oct 2016; status: completed.
02
Drugs
dulaglutide
03
Conditions
primary polydipsia (PP)water-electrolyte imbalance
Beyond the preview
Go deeper on NCT03141632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03141632.